Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.
暂无分享,去创建一个
Sandra S Stinnett | Cynthia A Toth | Scott W Cousins | Lejla Vajzovic | Stefanie G. Schuman | Lejla Vajzovic | C. Toth | U. Luhmann | S. Stinnett | E. Lad | S. Cousins | Stefanie G Schuman | Kimberly J Cocce | Ulrich F O Luhmann | Anupama Horne | Eleonora M Lad | K. Cocce | A. Horne | Anupama Horne
[1] R. Hays,et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators , 1998 .
[2] Ivana K. Kim,et al. Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration. , 2014, Investigative ophthalmology & visual science.
[3] M. Wintergerst,et al. Association of Vision-related Quality of Life with Visual Function in Age-Related Macular Degeneration , 2019, Scientific Reports.
[4] U. Schmidt-Erfurth,et al. Randomized Trial to Evaluate Tandospirone in Geographic Atrophy Secondary to Age-Related Macular Degeneration: The GATE Study. , 2015, American journal of ophthalmology.
[5] A. Althouse. Adjust for Multiple Comparisons? It's Not That Simple. , 2016, The Annals of thoracic surgery.
[6] C. Mangione,et al. Influence of age-related maculopathy on visual functioning and health-related quality of life. , 1999, American journal of ophthalmology.
[7] L. Ayton,et al. Low-luminance visual acuity and microperimetry in age-related macular degeneration. , 2014, Ophthalmology.
[8] L. Ayton,et al. Longitudinal changes in microperimetry and low luminance visual acuity in age-related macular degeneration. , 2015, JAMA ophthalmology.
[9] Jennifer H. Acton,et al. Microperimetry in Age-Related Macular Degeneration: An Evidence-Base for Pattern Deviation Probability Analysis in Microperimetry , 2019, Translational vision science & technology.
[10] Jeff Rabin,et al. Rapid quantification of color vision: the cone contrast test. , 2011, Investigative ophthalmology & visual science.
[11] D M Snodderly,et al. Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. , 1995, The American journal of clinical nutrition.
[12] F. Ferris,et al. New visual acuity charts for clinical research. , 1982, American journal of ophthalmology.
[13] Christine A. Curcio,et al. The spatial resolution capacity of human foveal retina , 1989, Vision Research.
[14] N. Notaroberto,et al. Detection of Macular Function Changes in Early (AREDS 2) and Intermediate (AREDS 3) Age-Related Macular Degeneration , 2010, Ophthalmologica.
[15] Usha Chakravarthy,et al. Clinical classification of age-related macular degeneration. , 2013, Ophthalmology.
[16] Weng Tao,et al. Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. , 2012, Investigative ophthalmology & visual science.
[17] Kang Zhang,et al. Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study. , 2014, Ophthalmology.
[18] Gary S Rubin,et al. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. , 2008, Ophthalmology.
[19] G. Ying,et al. Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. , 2012, Ophthalmology.
[20] Peter K Kaiser,et al. Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis). , 2009, Transactions of the American Ophthalmological Society.
[21] K J Rothman,et al. No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.
[22] Cynthia Owsley,et al. Development of a questionnaire to assess vision problems under low luminance in age-related maculopathy. , 2006, Investigative ophthalmology & visual science.
[23] M. J. Perez-Carrasco,et al. Impaired mesopic visual acuity in eyes with early age-related macular degeneration. , 2012, Investigative ophthalmology & visual science.
[24] K. Rothman. Six Persistent Research Misconceptions , 2014, Journal of general internal medicine.
[25] Lyndon da Cruz,et al. Development of human embryonic stem cell therapies for age-related macular degeneration , 2013, Trends in Neurosciences.
[26] David I W Phillips,et al. Lutein and zeaxanthin status and risk of age-related macular degeneration. , 2003, Investigative ophthalmology & visual science.
[27] Cynthia Owsley,et al. Cone- and rod-mediated dark adaptation impairment in age-related maculopathy. , 2007, Ophthalmology.
[28] T. Sarna,et al. Zeaxanthin in combination with ascorbic acid or alpha-tocopherol protects ARPE-19 cells against photosensitized peroxidation of lipids. , 2004, Free radical biology & medicine.
[29] R. Raman,et al. Association of macular pigment optical density with risk factors for wet age-related macular degeneration in the Indian population , 2012, Eye.
[30] M. Varano,et al. MACULAR FUNCTION IN EYES WITH EARLY AGE-RELATED MACULAR DEGENERATION WITH OR WITHOUT CONTRALATERAL LATE AGE-RELATED MACULAR DEGENERATION , 2007, Retina.
[31] Stefanie G. Schuman,et al. VISUAL FUNCTION MEASURES IN EARLY AND INTERMEDIATE AGE-RELATED MACULAR DEGENERATION , 2016, Retina.
[32] Cynthia Owsley,et al. Early age-related maculopathy and self-reported visual difficulty in daily life. , 2002, Ophthalmology.
[33] Richard A. Bone,et al. Optical density spectra of the macular pigmentin vivo andin vitro , 1992, Vision Research.
[34] Ningli Wang,et al. Measurement of macular pigment optical density among healthy Chinese people and patients with early-stage age-related macular degeneration. , 2015, International journal of ophthalmology.
[35] G. R. Jackson,et al. Comparison of Visual Function in Older Eyes in the Earliest Stages of Age-related Macular Degeneration to Those in Normal Macular Health , 2016, Current eye research.
[36] R. Klein,et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.
[37] S. Beatty,et al. Concordance of macular pigment measurements obtained using customized heterochromatic flicker photometry, dual-wavelength autofluorescence, and single-wavelength reflectance. , 2013, Experimental eye research.
[38] J. Sahel,et al. RANDOMIZED CLINICAL TRIAL FRANCE DMLA2: Effect of Trimetazidine on Exudative and Nonexudative Age-RelatedMacular Degeneration , 2012, Retina.
[39] Sotiris Plainis,et al. Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age‐related macular degeneration (AMD) , 2011, Acta ophthalmologica.
[40] A. Bird,et al. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. , 2004, Investigative ophthalmology & visual science.
[41] E. Ghafar-Zadeh,et al. Recent Advances of Computerized Graphical Methods for the Detection and Progress Assessment of Visual Distortion Caused by Macular Disorders , 2019, Vision.
[42] P. Bernstein,et al. Studies on the singlet oxygen scavenging mechanism of human macular pigment. , 2007, Archives of biochemistry and biophysics.